Latest
Hot
Regarding the understanding of technical analysis
Technical analysis is a skill that sets aside fundamental analysis to use market sentiment for new stock trading. This approach is often used during market uptrends. The author prefers to use technical analysis for new stock trading, being able to handle both hot and cold new stocks. The advantages are higher chances of successful lotteries and easy purchases. The disadvantages include the risk of price drops, even significant ones, as well as the risk of first-day price drops or dark trading, making it challenging for long-term holding.
Fundamental analysis focuses on new stocks with excellent fundamentals. The benefits include predictable profits or substantial profits. The drawbacks are lower chances of successful lotteries due to intense competition and potential loss of interest. Combining both methods, the author believes that each has its pros and cons, which can be balanced.
Let's now carefully analyze the technical support for investing in Xianruida. Currently, the market sentiment is declining, so it definitely does not support new stock trading. Looking at the recent performance of new listings, there are no highly profitable stocks. The only recent new listing, Li Auto, experienced a price drop. In this scenario, why would the author still choose Xianruida? It's because the author has noticed some subtle details.
Basic fundamental analysis is needed here. Xianruida leads in a specific niche market, focusing on two products. One product has captured a market share of 86.9%, while the other is also a market leader. See the chart for details.
13 cornerstone investors took 50% of the shares, mostly domestic funds and unknown cornerstone investors, without the presence of foreign star cornerstone investors, which is the first point of controversy. The post-valuation is around 7 billion, with a 15% increase from the last round of financing, which is indeed a very conscientious valuation increase compared to the previous medical stocks that usually doubled or tripled in valuation after issuance.
Technical analysis is a skill that sets aside fundamental analysis to use market sentiment for new stock trading. This approach is often used during market uptrends. The author prefers to use technical analysis for new stock trading, being able to handle both hot and cold new stocks. The advantages are higher chances of successful lotteries and easy purchases. The disadvantages include the risk of price drops, even significant ones, as well as the risk of first-day price drops or dark trading, making it challenging for long-term holding.
Fundamental analysis focuses on new stocks with excellent fundamentals. The benefits include predictable profits or substantial profits. The drawbacks are lower chances of successful lotteries due to intense competition and potential loss of interest. Combining both methods, the author believes that each has its pros and cons, which can be balanced.
Let's now carefully analyze the technical support for investing in Xianruida. Currently, the market sentiment is declining, so it definitely does not support new stock trading. Looking at the recent performance of new listings, there are no highly profitable stocks. The only recent new listing, Li Auto, experienced a price drop. In this scenario, why would the author still choose Xianruida? It's because the author has noticed some subtle details.
Basic fundamental analysis is needed here. Xianruida leads in a specific niche market, focusing on two products. One product has captured a market share of 86.9%, while the other is also a market leader. See the chart for details.
13 cornerstone investors took 50% of the shares, mostly domestic funds and unknown cornerstone investors, without the presence of foreign star cornerstone investors, which is the first point of controversy. The post-valuation is around 7 billion, with a 15% increase from the last round of financing, which is indeed a very conscientious valuation increase compared to the previous medical stocks that usually doubled or tripled in valuation after issuance.
+3
30
41
56
Unlock Pro Investors’ Money-Making Secrets
Join Futubull Community! Now Connect Directly with Top Investors & Public Company Executives